Gynecologic cancer patients at risk of insurance loss, ‘catastrophic’ costsMarch 25, 2021Gynecologic Cancer
Frail status may be better than age for predicting ovarian cancer outcomesMarch 24, 2021Gynecologic Cancer
Study: Gynecologic cancer therapy does not increase COVID-19 risksMarch 22, 2021Gynecologic CancerCOVID-19 Updates
Intervention reduced racial disparities among patients in cancer trialsMarch 21, 2021Gynecologic CancerDiversity in Medicine
Delaying surgery didn’t impact survival in early-stage cervical cancerMarch 21, 2021Gynecologic Cancer
Rucaparib extends PFS in BRCA-mutated ovarian cancer, with an exceptionMarch 21, 2021Gynecologic Cancer
SNP chips deemed ‘extremely unreliable’ for identifying rare variantsMarch 17, 2021Breast CancerGynecologic CancerGenitourinary CancerGastrointestinal CancerPatient & Survivor CareMixed Topics
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareDLBCLCOVID-19 UpdatesBreast CancerCNS/Brain CancerFollicular LymphomaGastrointestinal Cancer
Vaginal pH may predict CIN 2 progression in HIV-positive womenMarch 12, 2021Mixed TopicsGynecologic Cancer
mCODE: Improving data sharing to enhance cancer careMarch 12, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?March 5, 2021Breast CancerGynecologic CancerPatient & Survivor Care
Bladder cancer indication withdrawn for durvalumabMarch 1, 2021Genitourinary CancerGynecologic Cancer
